Copyright
©2013 Baishideng.
World J Pharmacol. Mar 9, 2013; 2(1): 35-46
Published online Mar 9, 2013. doi: 10.5497/wjp.v2.i1.35
Published online Mar 9, 2013. doi: 10.5497/wjp.v2.i1.35
Transporter | Expression (tissue/cell type/localization) | Physiological substrates | Select drug substrates | Guidance |
P-gp | Brain/endothelial cell/apical | Phospholipids, cytokines, steroids | Aliskiren, ambrisentan, colchicine, dabigatran etexilate, digoxin, everolimus, fexofenadine, imatinib, indinavir, itraconazole, lapatinib, maraviroc, nilotinib, paclitaxel, posaconazole, ranolazine, saxagliptin, sirolimus, sitagliptin, talinolol, tolvaptan, topotecan, vinca alkaloids | FDA/ EMA |
Kidney/epithelial cell/apical | ||||
Liver/hepatocyte/canalicular | ||||
Small intestine/enterocyte/apical | ||||
(colon) | ||||
BCRP | Brain/endothelial cell/apical | Vitamins (riboflavin, biotin), porphyrins, estrogen sulfate conjugates | Methotrexate, mitoxantrone, daunorubicin, doxorubicin, imatinib, irrinotecan, lapatinib, rosuvastatin, pitavastatin, provastatin, sulfasalazine, topotecan | FDA/ EMA |
Liver/hepatocyte/canalicular | ||||
Small intestine/enterocyte/apical | ||||
Kidney/epithelial cell/apical | ||||
Placenta/syncytiotrophoblast/apical (maternal) | ||||
BSEP | Liver/hepatocyte/canalicular | Taurocholate, glycocholate | Pravastatin, paclitaxel, vinblastine | EMA |
OATP1B1 | Liver/hepatocyte/basolateral | Bilirubin and its conjugates, thyroxin, triiodothyronine, bile acids, eicosanoids (thromboxane B2, prostaglandin E2, leukotriene C4), dehydroepiandrosterone sulfate, estradiol 17β-glucuronide, estrone 3-sulfate, glycocholate | Atrasentan, atorvastatin, bosentan, ezetimibe, fluvastatin, glyburide, methotrexate, olmesartan, pitavastatin, pravastatin, repaglinide, rifampin, rosuvastatin, simvastatin acid, SN-38 (active metabolite of irinotecan), valsartan | FDA/ EMA |
OATP1B3 | Liver/hepatocyte/basolateral | Estradiol 17β-glucuronide, taurocholate, estrone 3-sulfate, dehydroepiandrosterone sulfate, thyoxin | Atorvastatin, bosentan, digoxin, methotrexate, olmesartan, paclitaxel, pitavastatin, rosuvastatin, telmisartan, valsartan | FDA/ EMA |
OAT1 | Kidney/proximal tubular cell/basolateral | Para-aminohippuric acid, homocysteine, Cysteine,dicarboxylates, prostaglandine E2, urate, estrone-3-sulfate | Adefovir, captopril, cidofovir, furosemide, lamivudine, methotrexate, oseltamivir, tenofovir, zalcitabine, zidovudine | FDA/ EMA |
OAT3 | Kidney/proximal tubular cell/basolateral | Estrone 3-sulfate, estradiol 17β-glucoronide, cAMP, taurocholate, cortisol, dehydroepiandrosterone sulfate, prostaglandine E2, urate, succinate, para-aminohippuric acid | Acyclovir, bumetanide, ciprofloxacin, famotidine, furosemide, methotrexate, oseltamivir acid, (the active metabolite of oseltamivir), penicillin G, pravastatin, rosuvastatin, sitagliptin, valacyclovir, zidovudine | FDA/ EMA |
1-Oct | Liver/hepatocyte/basolateral | Corticosterone, β-oestradiol, progesterone, testosterone, choline, creatinine, guanidine, L-carnitine, thiamine, thyramine, acetylcholine, dopamine | Acyclovir, amantadine, gancyclovir, imatinib, lamivudin, metformin, oxaliplatin, quinidine, quinine, ranitidine, zalcitabine | EMA |
Small intestine/enterocyte/basolateral | ||||
2-Oct | Kidney/epithelial cell/ basolateral | β-oestradiol, progesterone, testosterone, choline, creatinine, guanidine, L-carnitine, acetylcholine, dopamine, epinephrine, norepinephrine, histamin, serotonin, choline, dopamine, prostagladine E2 | Amantadine, amilorid, cimetidine, cisplatin, dofetilide, famotidine, lamivudin, metformin, oxaliplatin, pindolol, procainamide, ranitidine, zalcitabine | FDA/ EMA |
MATE1 | Kidney/epithelial cell/apical | Choline, creatinine, guanidine, corticosterone, estrone 3-sulfate, thiamine | Acyclovir, cimetidine, fexofenadine, gancyclovir, metformin, procainamide, topotecan | EMA |
Liver/hepatocyte/canalicular | ||||
MATE2/MATE2K | Kidney/epithelial cell/apical | Choline, creatinine, guanidine, corticosterone, estrone 3-sulfate, thiamine | Acyclovir, cimetidine, gancyclovir, metformin, procainamide, topotecan | EMA |
- Citation: Krajcsi P. Drug-transporter interaction testing in drug discovery and development. World J Pharmacol 2013; 2(1): 35-46
- URL: https://www.wjgnet.com/2220-3192/full/v2/i1/35.htm
- DOI: https://dx.doi.org/10.5497/wjp.v2.i1.35